Search Results - Jochen G. Mainz

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Cover Image

    Proliferative activity of antigen-specific CD154+ T cells against bacterial and fungal respiratory pathogens in cystic fibrosis decreases after initiation of highly effective CFTR... by Patience N. Eschenhagen, Patience N. Eschenhagen, Patience N. Eschenhagen, Petra Bacher, Petra Bacher, Claudia Grehn, Jochen G. Mainz, Jochen G. Mainz, Alexander Scheffold, Carsten Schwarz, Carsten Schwarz, Carsten Schwarz

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Prevalence of constipation in cystic fibrosis patients: a systematic review of observational studies by Marina A. Stefano, Rosana E. Poderoso, Jochen G. Mainz, Jose D. Ribeiro, Antonio F. Ribeiro, Elizete Aparecida Lomazi

    Published 2020
    Connect to this object online.
    Book

    Save to List
    Saved in:
  3. 3
    Cover Image

    Prevalence of constipation in cystic fibrosis patients: a systematic review of observational studies by Marina A. Stefano, Rosana E. Poderoso, Jochen G. Mainz, Jose D. Ribeiro, Antonio F. Ribeiro, Elizete Aparecida Lomazi

    Published 2020
    Connect to this object online.
    Book

    Save to List
    Saved in:
  4. 4
    Cover Image

    Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score by Jochen G. Mainz, Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Ludwik Kurzidim, Patience Eschenhagen, Laura Caley, Daniel Peckham, Daniel Peckham, Carsten Schwarz

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:
  5. 5
    Cover Image

    Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score by Jochen G. Mainz, Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Ludwik Kurzidim, Patience Eschenhagen, Laura Caley, Daniel Peckham, Daniel Peckham, Carsten Schwarz

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:
  6. 6
    Cover Image

    Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy by Ulrike Müller, Julia Hentschel, Wibke K. Janhsen, Kerstin Hünniger, Uta-Christina Hipler, Jürgen Sonnemann, Wolfgang Pfister, Klas Böer, Thomas Lehmann, Jochen G. Mainz

    Published 2015
    Connect to this object online.
    Book

    Save to List
    Saved in:
  7. 7
    Cover Image

    Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire by Jochen G. Mainz, Jochen G. Mainz, Anton Barucha, Anton Barucha, Pu Huang, Pu Huang, Lilith Bechinger, Lilith Bechinger, Franziska Duckstein, Franziska Duckstein, Louise Polte, Louise Polte, Pauline Sadrieh, Pauline Sadrieh, Lutz Nährlich, Olaf Eickmeier, Suzanne Van Dullemen, Patience Eschenhagen, Carsten Schwarz, Stefan Lüth, Carlos Zagoya, Carlos Zagoya, Ute Graepler-Mainka

    Published 2023
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: